In human melanoma cell lines A2058, SK-MEL-2, SK-MEL-5, and SK-MEL-28, PV001-DV was shown to induce cell death via apoptosis and increase PD-L1 expression, which may contribute to an enhanced oncolytic effect when combined with anti-PD-L1 therapy. The gene discussed is CD274; the disease is melanoma.